Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

20%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 2Efficacy & side effects

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(2)

Detailed Status

Recruiting2

Completed2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (50.0%)

N/A1 (50.0%)

Trials by Status

recruiting240%

completed240%

not_yet_recruiting120%

Recent Activity

2 active trials

Showing 5 of 5

not_yet_recruitingnot_applicable

Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2

NCT03387787

Clinical Trials (5)

Showing 5 of 5 trials

NCT07645079Not Applicable

Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes Care

Not Yet Recruiting

NCT06605859

DigiDiab Pilot Spain - Nursing Home and Domiciliary Nursing Care

Recruiting

NCT06616779

DigiDiab Evaluation Domiciliary Nursing Care

Completed

NCT06605872

DigiDiab Pilot: Impact Study Hospital

Recruiting

NCT03387787Phase 2

Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2

Completed

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5